Infant Formula Regulation: Future Direction

Infant formula regulation in China over the last decade has been inextricably linked and shaped by the vagaries of market dynamics, protectionist policies and technical capacity disparities between China and its international competitors. While the sheer scale of the market makes it a mouthwatering prospect for international and domestic dairy enterprise and investors, the volume and value of the market belies the true risk inherent in China infant formula sector market entry. Risk and rewards are equally great, and the road to success in China’s infant formula sector is littered with the carcasses of less savvy investors or enterprise unable to buffer the disruptive influence of constant regulatory change over the last several years. Accepting that risk is inevitable are there any metrics or information we can use to guide safer investment? Is this even possible, given that companies like Bellamy’s (with multimillion dollar consultancy budgets) have failed in China due to the destabilizing influence of new regulations. Are there any signs of what is likely to happen over the next several months and in the coming years? Here are our 4 predictions:

Please Log in or Sign up (FREE) to read the full content.
Copyright: unless otherwise stated all contents of this website are ©2020 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact cleditor@chemlinked.com
Yilia Ye
ChemLinked Regulatory Analyst
Yilia is head editor of Chemlinked food portal and also an experienced food regulation analyst at REACH24h Consulting Group. Her broad experience in the food sector in China has afforded her unique insight on key areas including CBEC, dairy products, infant formula and health food. She is recognized as a knowledgeable expert in food regulation sector and has delivered speeches in multiple industry conferences such as Dairy Asia Pacific Summit 2018.
A total of 307 articles more